Prognosis and expression of lambda light chains in solitary extramedullary plasmacytoma of the head and neck: Two case reports and a literature review

Journal of International Medical Research

Volumn 38, Issue 1, 2010, Pages 282-288

  Liu, H Y ^a   Luo, X M ^a   Zhou, Shui Hong ^a   Zheng, Z J ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Extramedullary plasmacytoma; Lambda light chain; Prognosis

Indexed keywords

ADULT; ARTICLE; B SCAN; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; EXTRAMEDULLARY PLASMACYTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNAL JUGULAR VEIN; LAMBDA LIGHT CHAIN; LARYNGOSCOPY; LIGHT CHAIN; MALE; NECK CANCER; PLASMACYTOMA; PROGNOSIS; RADIATION DOSE; STAINING; STERNOCLEIDOMASTOID MUSCLE; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 77749277415     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800133     Document Type: Article

References (19)

1. Bachar G, Goldstein D, Brown D, et al: Solitary extramedullary plasmacytoma of the head and neck - long-term outcome analysis of 68 cases. Head Neck 2008; 30: 1012-1019.
2. Galieni P, Cavo M, Pulsoni A, et al: Clinical outcome of extramedullary plasmacytoma. Haematologica 2000; 85: 47-51.
3. Susnerwala SS, Shanks JH, Banerjee SS, et al: Extramedullary plasmacytoma of the head and the neck region: clinicopathological correlation in 25 cases. Br J Cancer 1997; 75: 921-927.
4. Bartl R, Frisch B, Fateh-Moghadam A, et al: Histological classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987; 87: 342-355.
5. Alexiou C, Kau RJ, Dietzfelbinger H, et al: Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999; 85: 2305-2314.
6. Galieni P, Cavo M, Avvisati G, et al: Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol 1995; 6: 687-691.
7. Tsang RW, Gospodarowicz MK, Pintilie M, et al: Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 2001; 50: 113-120.
8. Bolek TW, Marcus RB, Mendenhall NP: Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1996; 36: 329-333.
9. Soutar R, Lucraft H, Jackson G, et al: Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 2004; 16: 405-413.
10. Liebross RH, Ha CS, Cox JD, et al: Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 1998; 41: 1063-1067.
11. Mendenhall CM, Thar TL, Million RR: Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1980; 6: 1497-1501.
12. Frassica D, Frassica FJ, Schray MF, et al: Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989; 16: 43-48.
13. Hu K, Yahalom J: Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park) 2000; 14: 101-108.
14. Ozsahin M, Tsang RW, Poortmans P, et al: Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys 2006; 64: 210-217.
15. Majumdar S, Raghavan U, Jones NS: Solitary plasmacytoma and extramedullary plasmacytoma of the paranasal sinuses and soft palate. J Laryngol Otol 2002; 116: 962-965.
16. Mock PM, Neal GD, Aufdemorte TB: Immunoperoxidase characterization of extramedullary plasmacytoma of the head and neck. Head Neck Surg 1987; 9: 356-361.
17. Knobel D, Zouhair A, Tsang RW, et al for the Rare Cancer Network: Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer 2006; 6: 118.
18. Kilciksiz S, Celik OK, Pak Y, et al: Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group - Sarcoma Working Party. Am J Hematol 2008; 83: 702-707.
19. Wilder RB, Ha CS, Cox JD, et al: Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer 2002; 94: 1532-1537.